My Top 10 Stocks to Buy for 2026

Together, these stocks offer you a balanced mix of growth and safety. These companies span a number of industries, and many are leaders in their markets.

The Motley Fool • Dec 13, 2025

UnitedHealth Group Announces Earnings Release Date

--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) will release its full year 2025 financial results and provide 2026 financial guidance on Tuesday, January 27, 2026, before the market opens, and will host a teleconference at 8:00 a.m. ET with analysts and investors. This call will be webcast on the Investor Relations page of the company's website (www.unitedhealthgroup.com). The replay will be available through February 10 on the website. About UnitedHealth Group UnitedHealth Group (NYSE: UNH).

Business Wire • Dec 12, 2025

UnitedHealth Group: This Top-Notch Dividend Grower Is Staging A Comeback

UnitedHealth Group remains a core dividend growth holding, benefiting from demographic tailwinds and a dominant healthcare ecosystem role. Despite a 41.1% EPS drop in 2025 from elevated medical care ratios, revenue grew 12.2% year-over-year, and long-term growth catalysts remain intact. UNH trades at a forward P/E of 18.9, about 7% below its 10-year average, offering a potential 13% total return by the end of 2026 if growth targets are met.

Seeking Alpha • Dec 12, 2025

S&P 500 Stocks: UnitedHealth, Centene Rise Amid Push For House ACA Vote

A discharge petition could force the GOP's hand.

Investors Business Daily • Dec 12, 2025

UnitedHealth's 2026 Could Surprise The Street

UnitedHealth crashed over 40% YTD as seniors' utilization spiked and MLR neared 90%, but the stock has already rebounded ~25% since my mid‑May Buy. The Q3 showed 12% revenue growth and a 4% EPS beat despite ugly optics; management called trends historically high but consistent, signaling no new MLR shock emerging. UNH is deliberately exiting and repricing uneconomic Medicare Advantage business — shrinking MA membership by ~1 million while pushing double‑digit rate increases to structurally lift margins per remaining member.

Seeking Alpha • Dec 12, 2025

UnitedHealth: A Long-Term Compounder Worth Holding Through Any Cycle

UnitedHealth remains a "Buy" with a $400 price target, reflecting 19% upside and continued market outperformance potential. UNH delivered a Q3 2025 double-beat, posting 12% revenue growth and exceeding both top- and bottom-line estimates. Despite strong results, the stock experienced a post-earnings pullback, likely due to profit-taking after a 44% rally since August.

Seeking Alpha • Dec 12, 2025

Eight stock picks to play one of the healthiest corners of the market

The healthcare sector of the U.S. stock market as a whole is cheaply priced, which can make it attractive to investors concerned that the S&P 500 has gotten too expensive several years into a bull market.

Market Watch • Dec 11, 2025

Behind the Curtain: How UnitedHealth is Rewriting its Own Rules

UNH is reshaping its model with tech-driven, integrated care as Optum's growth and rising revenues redefine its strategy.

Zacks Investment Research • Dec 10, 2025

Meet the 2.5% Yield Dividend Stock That Could Soar in 2026

UnitedHealth Group stock is trading at an attractive price-to-earnings ratio right now. UnitedHealth's management has a solid plan to improve profit margins.

The Motley Fool • Dec 9, 2025

UNH Stock: Can UnitedHealth Recover From 2025's Turbulence?

UnitedHealth's stock has generally underperformed compared to some rivals over the last year, but how does it stand against competitors in the ever-changing healthcare landscape? An in-depth analysis shows strong profitability, consistent revenue growth, and reasonable valuation support.

Forbes • Dec 9, 2025